Keisuke Aoki

Mie Chuo Medical Center, Tokyo Medical Center

Papers

6

Total Citations

25

H-Index

4

About

Dr. Keisuke Aoki is a pioneering urologic surgeon and researcher whose work centers on refining robot-assisted radical prostatectomy (RARP) and advancing minimally invasive treatments for prostate cancer and benign prostatic hyperplasia (BPH). His major contributions lie in surgical anatomy and functional outcomes—most notably, his detailed characterization of the superficial preprostatic vein (SPV) and accessory pudendal artery (APA). By analyzing over 500 patients, Dr. Aoki established predictive factors for immediate post-surgical continence and developed preservation techniques for the APA during RARP, directly improving patient quality of life. His impact is reflected in his highly cited papers, including the landmark 2024 study on continence predictors (7 citations) and the first-ever case report of salvage RARP after heavy ion radiotherapy (5 citations). Dr. Aoki has also expanded the therapeutic landscape for BPH, evaluating the AQUABEAM robotic system for Aquablation in Japanese populations, demonstrating its safety and efficacy. His work bridges meticulous anatomical insight with clinical innovation, earning him recognition as a leading voice in robotic urologic surgery and functional recovery.

Research Focus

Key Achievements

4
H-Index
6
Papers
25
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Predictive factors of immediate continence after conventional robot-assisted radical prostatectomy: a single-institution retrospective study
7 citations · 2024
📈 Most Prolific Year: 2024 (4 Papers)
🤝 Key Collaborators: 34
🏛 Institutions: Mie Chuo Medical Center, Tokyo Medical Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago